Taken together, this data suggests that asymmetric protein L-arginine methylation may be a differentially upregulated process in BC tumor biology; BC cells protect themselves from the potentially cytotoxic effects of dimethylarginines by upregulating their DDAH-mediated breakdown to L-citrulline and dimethylamine. The gene discussed is DDAH1; the disease is breast cancer.